A randomized Phase I/II study to evaluate safety and reactogenicity of a heat-stable rotavirus vaccine in healthy adults followed by evaluation of the safety, reactogenicity, and immunogenicity in infants

Objectives: To assess the safety and reactogenicity of single oral dose of heat-stable rotavirus vaccine (HSRV) in healthy adults aged 18–45 years followed by assessment of safety, reactogenicity, and immunogenicity of three doses of HSRV in healthy infants aged 6–8 weeks at enrollment. Trial Design...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Hum Vaccin Immunother
Main Authors: Kanchan, Vibhu, Zaman, Khalequ, Aziz, Asma Binte, Zaman, Sheikh Farzana, Zaman, Farzana, Haque, Warda, Khanam, Mahbuba, Karim, Mohammad Mahbubul, Kale, Sachin, Ali, Syed Khalid, Goveia, Michelle G., Kaplan, Susan S., Gill, Davinder, Khan, Wasif Ali, Yunus, Mohammad, Singh, Ajitpal, Clemens, John D.
פורמט: Artigo
שפה:Inglês
יצא לאור: Taylor & Francis 2019
נושאים:
Research Paper
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7227685/
https://ncbi.nlm.nih.gov/pubmed/31526218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1664239
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים